|
| |
| | | 67257 | | 20.01.2020 | | AbbVie AG | | | | | | | | | | | | | 70000. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rinvoq 15 mg | Retardtabletten | Delayed release tablets (Upadacitinibum 15 mg) | L04AF03 | CI | | 05 | Rinvoq 30 mg | Retardtabletten | Delayed release tablets (Upadacitinibum 30 mg) | L04AF03 | CI | | 06 | Rinvoq 45 mg | Retardtabletten | Delayed release tablets (Upadacitinibum 45 mg) | L04AF03 | CI |
|
|
|
